Clinical Trial Update: Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a treatment for tobacco use disorder in individuals with schizophrenia, examining effects on craving, cues, and withdrawal, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: VA Boston Healthcare System | Conditions: Tobacco Use Disorder | Phase 4 | Status: WITHDRAWN